Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "UP"

7650 News Found

Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection
Drug Approval | June 08, 2022

Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection

he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.


Lupin receives tentative approval from FDA for Ivacaftor tablets
Drug Approval | June 08, 2022

Lupin receives tentative approval from FDA for Ivacaftor tablets

Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.


Fortis Healthcare opens Healthcare Information Centre at Tirupati
Healthcare | June 04, 2022

Fortis Healthcare opens Healthcare Information Centre at Tirupati

The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.


DuPont opens new biopharma tubing manufacturing site in US
News | June 02, 2022

DuPont opens new biopharma tubing manufacturing site in US

The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan


USFDA accepts dupilumab for priority review in adults with prurigo nodularis
Drug Approval | June 01, 2022

USFDA accepts dupilumab for priority review in adults with prurigo nodularis

Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved


Blockchain improves product authenticity in supply chain, finds GlobalData
Supply Chain | May 30, 2022

Blockchain improves product authenticity in supply chain, finds GlobalData

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors


Strides receives USFDA approval for Ibuprofen Oral Suspension
Drug Approval | May 30, 2022

Strides receives USFDA approval for Ibuprofen Oral Suspension

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)


Augnito introduces key update to its Voice AI solution
Digitisation | May 26, 2022

Augnito introduces key update to its Voice AI solution

The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model


Lonza partners with Israel Biotech Fund to support biologics and small molecules development
Biotech | May 25, 2022

Lonza partners with Israel Biotech Fund to support biologics and small molecules development

The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets


Piramal Pharma Solutions upgrades Pithampur site
News | May 25, 2022

Piramal Pharma Solutions upgrades Pithampur site

New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses